Literature DB >> 25241255

Caveolin and cavin family members: dual roles in cancer.

Reshu Gupta1, Chirine Toufaily2, Borhane Annabi2.   

Abstract

Caveolae are specialized plasma membrane subdomains with distinct lipid and protein compositions, which play an essential role in cell physiology through regulation of trafficking and signaling functions. The structure and functions of caveolae have been shown to require the proteins caveolins. Recently, members of the cavin protein family were found to be required, in concert with caveolins, for the formation and function of caveolae. Caveolins have a paradoxical role in the development of cancer formation. They have been involved in both tumor suppression and oncogenesis, depending on tumor type and progress stage. High expression of caveolins and cavins leads to inhibition of cancer-related pathways, such as growth factor signaling pathways. However, certain cancer cells that express caveolins and cavins have been shown to be more aggressive and metastatic because of their increased potential for anchorage-independent growth. Here, we will survey the functional roles of caveolins and of different cavin family members in cancer regulation.
Copyright © 2014 Elsevier B.V. and Société française de biochimie et biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Cancer; Caveolin; Cavin

Mesh:

Substances:

Year:  2014        PMID: 25241255     DOI: 10.1016/j.biochi.2014.09.010

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  32 in total

1.  Cavin-1 is linked to lipid droplet formation in human hepatic stellate cells.

Authors:  Hiroaki Yokomori; Wataru Ando; Masaya Oda
Journal:  Med Mol Morphol       Date:  2019-03-15       Impact factor: 2.309

Review 2.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

3.  Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma.

Authors:  Fiorella Faggi; Nicola Chiarelli; Marina Colombi; Stefania Mitola; Roberto Ronca; Luca Madaro; Marina Bouche; Pietro L Poliani; Marika Vezzoli; Francesca Longhena; Eugenio Monti; Barbara Salani; Davide Maggi; Charles Keller; Alessandro Fanzani
Journal:  Lab Invest       Date:  2015-03-30       Impact factor: 5.662

4.  MicroRNA-451a targets caveolin-1 in stomach cancer cells.

Authors:  Yi Wang; Zhenmeng Lin; Jintian Song; Shenghong Wei; Zaisheng Ye; Shu Chen; Yi Zeng; Zhitao Lin; Xiaoling Chen; Luchuan Chen
Journal:  Int J Clin Exp Pathol       Date:  2020-10-01

5.  Caveolin-1-ACE2 axis modulates xenobiotic metabolism-linked chemoresistance in ovarian clear cell carcinoma.

Authors:  Arulkumar Nagappan; Ki-Hyung Kim; Yuseok Moon
Journal:  Cell Biol Toxicol       Date:  2022-05-27       Impact factor: 6.819

6.  Expression of the Cavin Family in Childhood Leukemia and Its Implications in Subtype Diagnosis and Prognosis Evaluation.

Authors:  Jing Yang; Junbin Huang; Huabin Wang; Yong Liu; Yanlai Tang; Chao Lin; Qin Zhou; Chun Chen
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

7.  Caveolin-1 is Markedly Downregulated in Patients with Early-Stage Colorectal Cancer.

Authors:  Blanca Torrejón; Ion Cristóbal; Federico Rojo; Jesús García-Foncillas
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

8.  Probing the structure and dynamics of caveolin-1 in a caveolae-mimicking asymmetric lipid bilayer model.

Authors:  Hanqi Liu; Linlin Yang; Qiansen Zhang; Lingxue Mao; Hualiang Jiang; Huaiyu Yang
Journal:  Eur Biophys J       Date:  2016-04-02       Impact factor: 1.733

9.  A Role for the Cavin-3/Matrix Metalloproteinase-9 Signaling Axis in the Regulation of PMA-Activated Human HT1080 Fibrosarcoma Cell Neoplastic Phenotype.

Authors:  Chirine Toufaily; Cyndia Charfi; Bayader Annabi; Borhane Annabi
Journal:  Cancer Growth Metastasis       Date:  2014-12-08

10.  Serum deprivation response inhibits breast cancer progression by blocking transforming growth factor-β signaling.

Authors:  Yao Tian; Yue Yu; Li-Kun Hou; Jiang-Rui Chi; Jie-Fei Mao; Li Xia; Xin Wang; Ping Wang; Xu-Chen Cao
Journal:  Cancer Sci       Date:  2016-02-13       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.